Table 2 The clinical and behavioral variables of the participants according to the CVD status in Kherameh cohort
Variable | CVD | No (n = 9552) n (%) | p value | |
|---|---|---|---|---|
|  |   All participants n (%) n = 10,663 | Yes (n = 1111) n (%) | ||
Diabetes | Â | Â | Â | Â |
 No | 9070 (85.1) | 799 (71.9) | 8271 (86.6) | < 0.001 |
 Yes | 1593 (14.9) | 312 (28.1) | 1281 (13.4) |  |
Cancer | Â | Â | Â | Â |
 No | 10,609 (99.5) | 1100 (99) | 9509 (99.5) | < 0.001 |
 Yes | 54 (0.5) | 11 (1) | 43 (0.5) |  |
COPD | Â | Â | Â | Â |
 No | 10,369 (97.2) | 1055 (95) | 9314 (97.5) | < 0.001 |
 Yes | 294 (2.8) | 56 (5) | 238 (2.5) |  |
High blood pressure | Â | Â | Â | Â |
 No | 8153 (76.5) | 463 (41.7) | 7690 (80.5) | < 0.001 |
 Yes | 2510 (23.5) | 648 (58.3) | 1862 (19.5) |  |
High cholesterol level | Â | Â | Â | Â |
 No | 7014 (65.8) | 772 (69.5) | 6242 (65.3) | 0.006 |
 Yes | 3649 (34.2) | 339 (30.5) | 3310 (34.7) |  |
High triglyceride level | Â | Â | Â | Â |
 No | 7637 (71.6) | 760 (68.4) | 6877 (72.1) | 0.011 |
 Yes | 3018 (28.3) | 351 (31.6) | 2667 (27.9) |  |
HDL (mg/dl) | Â | Â | Â | Â |
 < 40 for males and < 50 for females | 4798 (45) | 515 (46.4) | 4283 (44.9) | 0.329 |
 ≥ 40 for males and ≥ 50 for females | 5860 (55) | 595 (53.6) | 5265 (55.1) |  |
White blood cell count (× 1000 cells/mm3) |  |  |  |  |
 < 5.8 | 4189 (39.3) | 390 (35.1) | 3799 (39.8) | 0.006 |
 5.8–7 | 3129 (29.3) | 337 (30.3) | 2792 (29.3) |  |
 > 7 | 3337 (31.3) | 384 (34.6) | 2953 (30.9) |  |
Opium use | Â | Â | Â | Â |
 No | 8949 (83.9) | 908 (81.8) | 8041 (84.2) | 0.039 |
 Yes | 1710 (16) | 202 (18.2) | 1508 (15.8) |  |
Hookah use | Â | Â | Â | Â |
 No | 10,115 (94.9) | 1062 (95.6) | 9053 (94.8) | 0.28 |
 Yes | 548 (5.1) | 49 (4.4) | 499 (5.2) |  |
Smoking | Â | Â | Â | Â |
 No | 7956 (74.6) | 797 (71.7) | 7163 (75) | 0.018 |
 Yes | 2704 (25.4) | 314 (28.3) | 2389 (25) |  |
Alcohol consumption | Â | Â | Â | Â |
 No | 10,095 (94.7) | 1066 (95.9) | 9029 (94.5) | 0.045 |
Median serum creatinine (mmol/l) | 0.9 (0.9, 1) |  |  | < 0.001 |